昊帆生物
(301393)
| 流通市值：21.62亿 | | | 总市值：57.86亿 |
| 流通股本：4035.90万 | | | 总股本：1.08亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 135,213,242.04 | 451,874,668.1 | 328,158,737.06 | 225,057,269.42 |
| 营业收入 | 135,213,242.04 | 451,874,668.1 | 328,158,737.06 | 225,057,269.42 |
| 二、营业总成本 | 102,006,985.59 | 320,336,611.16 | 228,599,500.59 | 151,713,429.68 |
| 营业成本 | 82,708,972.55 | 269,852,206.07 | 191,553,471 | 134,681,268.22 |
| 税金及附加 | 1,416,117.8 | 4,178,065.22 | 2,553,778.66 | 1,857,431.67 |
| 销售费用 | 3,832,441.99 | 13,596,937.8 | 9,686,865.68 | 7,533,851.66 |
| 管理费用 | 7,148,311.3 | 29,529,803.99 | 23,460,639.15 | 15,265,464.08 |
| 研发费用 | 9,861,294.55 | 35,991,848.34 | 26,225,248.09 | 16,908,969.96 |
| 财务费用 | -2,960,152.6 | -32,812,250.26 | -24,880,501.99 | -24,533,555.91 |
| 其中:利息费用 | 26,566.61 | 91,293.5 | 34,786.56 | 22,939.98 |
| 其中:利息收入 | 3,408,207.74 | 29,727,232.8 | 28,050,784.16 | 23,623,486.51 |
| 加:公允价值变动收益 | 1,317,903.57 | 5,636,108.35 | 8,537,868.52 | 1,848,635.62 |
| 加:投资收益 | 6,025,752.73 | 10,950,889.64 | 1,172,551.34 | 168,632.16 |
| 资产处置收益 | -93,989.15 | -32,052.89 | -58,976.15 | - |
| 资产减值损失(新) | -386,538.6 | -2,661,553.64 | -1,369,210.16 | -2,777,892.49 |
| 信用减值损失(新) | -1,141,392.53 | -2,509,435.62 | -3,248,675.25 | -2,965,500.21 |
| 其他收益 | 1,438,915.64 | 12,969,342.67 | 6,400,906.92 | 5,842,163.57 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 40,366,908.11 | 155,891,355.45 | 110,993,701.69 | 75,459,878.39 |
| 加:营业外收入 | 4,876.22 | 120,434.03 | 118,889.22 | 115,874.22 |
| 减:营业外支出 | 933.23 | 1,375,650.43 | 565,246.74 | 104,005.11 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 40,370,851.1 | 154,636,139.05 | 110,547,344.17 | 75,471,747.5 |
| 减:所得税费用 | 5,571,873.66 | 20,583,221.99 | 14,212,148.52 | 9,662,664.28 |
| 六、净利润 | 34,798,977.44 | 134,052,917.06 | 96,335,195.65 | 65,809,083.22 |
| 持续经营净利润 | 34,798,977.44 | 134,052,917.06 | 96,335,195.65 | 65,809,083.22 |
| 归属于母公司股东的净利润 | 34,798,977.44 | 134,052,917.06 | 96,335,195.65 | 65,809,083.22 |
| (一)基本每股收益 | 0.33 | 1.25 | 0.9 | 0.61 |
| (二)稀释每股收益 | 0.32 | 1.24 | 0.89 | 0.61 |
| 八、其他综合收益 | 25,030.11 | - | - | - |
| 归属于母公司股东的其他综合收益 | 25,030.11 | - | - | - |
| 九、综合收益总额 | 34,824,007.55 | 134,052,917.06 | 96,335,195.65 | 65,809,083.22 |
| 归属于母公司股东的综合收益总额 | 34,824,007.55 | 134,052,917.06 | 96,335,195.65 | 65,809,083.22 |
| 公告日期 | 2025-04-28 | 2025-04-11 | 2024-10-30 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |